HealthTech Member:


David Herbada (CEO) and Professor David Edwards (CTO, Founder) chat to us about their business Sonosine.

Tell us about Sonosine

Sonosine is a ’deep- tech’ company based in the UK, with a worldwide mission, to make our new type of medical imaging scanner accessible to all. We have developed and patented a new and advanced medical imaging technology (EMA), that makes high-quality medical diagnostics quicker, safer and more comfortable for patients.

Our EMA technology will be embedded into our first product, the Pulsar 1, that will be mobile and produce MRI-like images at the cost and experience of an ultrasound scan.

With roots in the UK science base and founded as a spin-out from the University of Oxford in 2015, at Sonosine we are committed to drawing on our deep technical and industrial expertise to improve the way clinicians can diagnose and treat their patients in primary care settings.

How long have you been an Eagle Labs member?

Since December 2019.

When did you start your business?


What's been your biggest highlight

The support that we have received from the Barclay’s Eagle Labs and the Northern Stars Programme, with its immersion into the Silicon Valley networks and the exciting times ahead. Sonosine (formerly known as Oxford Enhanced Medical) has recently revealed its new name and fresh brand identity. With this comes the launch of our new website.

What's been your biggest challenge?

One of the biggest hurdles for many medical technology companies, Sonosine being no exception, is gaining regulatory approvals in the country where the product will be used.

Advice for entrepreneurs starting out

Great science and great minds work best when they are exposed to the problem that they are trying to tackle in person, not through advisors or online sources.


Share this page

Go back to the top of the page